BPC-157 vs TB-500
A research-context comparison of two of the most-studied tissue-repair peptides.
Researchers frequently weigh BPC-157 against TB-500 (Thymosin Beta-4). Both appear in tissue-repair research, but they differ in mechanism and typical study context. Here is a side-by-side overview.
Side-by-side
| Attribute | BPC-157 | TB-500 |
|---|---|---|
| Peptide class | Synthetic pentadecapeptide | Thymosin beta-4 fragment |
| Studied mechanisms | FAK-paxillin, VEGFR2 and nitric-oxide pathways | Actin regulation and cell migration |
| Common research context | Tendon, ligament and gut-lining models | Broad tissue-repair and cardiac models |
| Physical form | Lyophilized powder | Lyophilized powder |
| Reconstitution | Bacteriostatic water | Bacteriostatic water |
| Often studied together | Yes — see the Wolverine blend | Yes — see the Wolverine blend |
Which does the research favor?
Neither replaces the other in the literature — they are frequently studied together. BPC-157 dominates gut and tendon-model research, while TB-500 appears more in broad tissue-migration and cardiac contexts. The right choice depends on the research question.
Explore both compounds
Each ships with its Certificate of Analysis. Many researchers run them together — the basis of the Wolverine blend.
For research use only. These products are intended solely for in-vitro laboratory research and are not for human or veterinary use. Nothing here is medical advice or a therapeutic claim.